A comparative and longitudinal study on endocrine changes related to ovarian function in patients with anorexia nervosa.
Screening of androgens and estrogens in blood and a GnRH test were performed in 20 female patients with anorexia nervosa and in 10 lean and 10 normal weight healthy control subjects. Both control groups had regular ovulatory menstrual cycles. The investigation was performed in the mid-follicular phase. Several variables showed significant differences between the groups; the levels of PRL, estrone, estradiol, progesterone, testosterone, androstenedione, and LH were lowest in the patients with anorexia nervosa. The lean control group showed intermediate values for progesterone, androstenedione, and, to a smaller extent, testosterone. The FSH response to GnRH was significantly higher in the patient group, corresponding to the pattern of late prepubertal girls. Ten patients were seen in a follow-up study. Five had resumption of the menstrual cycle, and the others still had amenorrhea. The two subgroups did not differ in either weight gain or the basal hormonal variables investigated. After weight gain an increased LH response to GnRH was observed in both subgroups. Patients who had resumption of the menstrual cycle showed a higher response of LH to GnRH, both before and after weight gain. The mean increase in LH after GnRH administration was significantly different between the two subgroups. The results suggest that the GnRH test may be useful to assess the stage of the disease and to predict the outcome, especially with regard to restoration of the menstrual cycle.
van Binsbergen
C J
CJ
Department of Obstetrics and Gynecology, St. Joseph Ziekenhuis, Eindhoven, The Netherlands.
Coelingh Bennink
H J
HJ
Odink
J
J
Haspels
A A
AA
Koppeschaar
H P
HP
D000328:Adult; D000568:Amenorrhea / Q000097:blood / Q000150:complications; D000728:Androgens / Q000097:blood; D000856:Anorexia Nervosa / Q000097:blood / Q000150:complications / Q000503:physiopathology*; D004967:Estrogens / Q000097:blood; D005260:Female; D005498:Follicular Phase / Q000187:drug effects / Q000502:physiology; D007987:Gonadotropin-Releasing Hormone / Q000008:administration & dosage; D006065:Gonadotropins, Pituitary / Q000097:blood; D006801:Humans; D008137:Longitudinal Studies; D010053:Ovary / Q000187:drug effects / Q000503:physiopathology*; D011379:Prognosis; D013851:Thinness / Q000097:blood
D000728:Androgens; D004967:Estrogens; D006065:Gonadotropins, Pituitary; D007987:Gonadotropin-Releasing Hormone